StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.98−0.08 (-7.56%)

Close on Nov 13, 2026Market cap $638.94KP/E –Yield –

Decoy Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Decoy Therapeutics's total assets was $8.79M at Sep 30, 2026. For fiscal 2025 it was $11.06M, up 265.8% from the year before. Over ten years it grew -19.4% a year on average. The highest annual figure on record is $95.07M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.06M+265.8%
FY2024Dec 31, 2024$3.02M-54.1%
FY2023Dec 31, 2023$6.59M-55.0%
FY2022Dec 31, 2022$14.65M-64.1%
FY2021Dec 31, 2021$40.83M+63.8%
FY2020Dec 31, 2020$24.93M+79.4%
FY2019Dec 31, 2019$13.89M+110.1%
FY2018Dec 31, 2018$6.61M-81.1%
FY2017Dec 31, 2017$34.99M-44.6%
FY2016Dec 31, 2016$63.21M-33.5%
FY2015Dec 31, 2015$95.07M+167.0%
FY2014Dec 31, 2014$35.61M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.79M+44.2%
Q2 FY2026Jun 30, 2026$9.00M+546.3%
Q1 FY2026Mar 31, 2026$8.42M+260.1%
Q4 FY2025Dec 31, 2025$11.06M+265.8%
Q3 FY2025Sep 30, 2025$6.10M+58.0%
Q2 FY2025Jun 30, 2025$1.39M-60.8%
Q1 FY2025Mar 31, 2025$2.34M-52.1%
Q4 FY2024Dec 31, 2024$3.02M-54.1%
Q3 FY2024Sep 30, 2024$3.86M-54.1%
Q2 FY2024Jun 30, 2024$3.55M-70.5%
Q1 FY2024Mar 31, 2024$4.88M-51.4%
Q4 FY2023Dec 31, 2023$6.59M-55.0%
Q3 FY2023Sep 30, 2023$8.40M-57.4%
Q2 FY2023Jun 30, 2023$12.06M-64.2%
Q1 FY2023Mar 31, 2023$10.06M-71.7%
Q4 FY2022Dec 31, 2022$14.65M-64.1%
Q3 FY2022Sep 30, 2022$19.72M-55.4%
Q2 FY2022Jun 30, 2022$33.65M-29.0%
Q1 FY2022Mar 31, 2022$35.51M-30.1%
Q4 FY2021Dec 31, 2021$40.83M+63.8%
Q3 FY2021Sep 30, 2021$44.26M+91.9%
Q2 FY2021Jun 30, 2021$47.40M+155.4%
Q1 FY2021Mar 31, 2021$50.77M+153.0%
Q4 FY2020Dec 31, 2020$24.93M+79.4%
Q3 FY2020Sep 30, 2020$23.06M+59.5%
Q2 FY2020Jun 30, 2020$18.56M+160.1%
Q1 FY2020Mar 31, 2020$20.07M+145.2%
Q4 FY2019Dec 31, 2019$13.89M+110.1%
Q3 FY2019Sep 30, 2019$14.46M+3.7%
Q2 FY2019Jun 30, 2019$7.14M-58.5%
Q1 FY2019Mar 31, 2019$8.18M-68.6%
Q4 FY2018Dec 31, 2018$6.61M-81.1%
Q3 FY2018Sep 30, 2018$13.94M-66.2%
Q2 FY2018Jun 30, 2018$17.21M-65.3%
Q1 FY2018Mar 31, 2018$26.03M-53.1%
Q4 FY2017Dec 31, 2017$34.99M-44.6%
Q3 FY2017Sep 30, 2017$41.21M–
Q2 FY2017Jun 30, 2017$49.63M–
Q1 FY2017Mar 31, 2017$55.50M–
Q4 FY2016Dec 31, 2016$63.21M–

More Decoy Therapeutics figures

See a number that looks wrong?